-

Mountainside Issues Warning on Kratom and Cychlorphine Following Ole Miss Student Deaths

NEW YORK--(BUSINESS WIRE)--Following the deaths of two University of Mississippi students, Mountainside is urging families and college communities to seek reliable information about kratom and cychlorphine, an emerging synthetic opioid.

“What we’re seeing isn’t just the emergence of new substances—it’s a fundamental shift in how quickly the drug landscape is changing,” said Jana Wu, LCSW, leading kratom expert and Director of Clinical Integration at Mountainside.

Share

Authorities reported finding retail-packaged kratom during two separate death investigations. They have not determined that kratom or any other substance contributed to either death, established that the deaths are connected, or reported finding cychlorphine in either case. Mountainside extends its condolences to the students’ families, friends and campus community.

“What we’re seeing isn’t just the emergence of new substances—it’s a fundamental shift in how quickly the drug landscape is changing,” said Jana Wu, LCSW, leading kratom expert, Director of Clinical Integration at Mountainside, and founder of the first clinician-led kratom support group, Let’s Talk Kratom. “Kratom and 7-OH, cychlorphine, novel synthetic opioids, counterfeit pills and substances we may not yet be routinely testing for are creating a much more complicated clinical picture. The name on a package or pill may not tell us the whole story of what someone is actually taking.”

Kratom is a plant-derived substance sold in powders, capsules and concentrated products. Retail availability does not guarantee that a product is safe. Cychlorphine is a separate synthetic opioid identified by international drug-monitoring authorities as an emerging threat. No connection between cychlorphine and the Ole Miss deaths has been confirmed.

Mountainside has a long history of identifying emerging cultural and substance-use trends and translating them into education and prevention. Giving families, campuses and communities the information and tools they need earlier helps prevent tragedies.

“New substances like cychlorphine are a reminder that prevention education can't be a one-time conversation,” said Laura Maguire, Vice President of Educational Partnerships at Mountainside. “When universities keep resources visible and teach students how to respond if a friend needs help, students feel prepared to reach out for themselves or others.”

Mountainside encourages parents and caregivers to ask students what they have heard, correct misinformation without judgment and discuss the risks of using unfamiliar substances.

About Mountainside Treatment Center
Mountainside Treatment Center is a nationally recognized behavioral health organization specializing in the treatment of substance use disorders and co-occurring mental health conditions. Through evidence-based care, innovative programming, and community partnerships, Mountainside helps build meaningful lives in recovery.

Contacts

Media Contact
Griffin Gonzales
Director, Media Relations
griffin.gonzales@mountainside.com
231-794-9450

Mountainside Treatment Center


Release Versions

Contacts

Media Contact
Griffin Gonzales
Director, Media Relations
griffin.gonzales@mountainside.com
231-794-9450

Social Media Profiles
More News From Mountainside Treatment Center

Mountainside Calls Attention to the Veterans We Aren't Reaching

CANAAN, Conn.--(BUSINESS WIRE)--This Veterans Day, Mountainside Treatment Center is calling attention to a critical question in veteran mental healthcare: Who is reaching the veterans who aren't connected to traditional support systems? According to the U.S. Department of Veterans Affairs' 2026 National Veteran Suicide Prevention Annual Report, 62% of veterans who died by suicide in 2024 had not received VA healthcare in the year they died or the preceding year. The finding highlights the impor...

Mountainside Warns About The Dangers of K-Holes And Why They're Scarier Than You Think

NEW YORK--(BUSINESS WIRE)--There has been a lot of talk lately about ketamine, but many people don’t understand the risks of a “K-hole,” the vernacular for the trance-like state it can produce. Ketamine is a dissociative anesthetic, used for decades in human and veterinary medicine to sedate patients and relieve pain. The Drug Enforcement Administration (DEA) notes that it distorts sight and sound and leaves users feeling disoriented and not in control. At higher recreational doses, the detachm...

Mountainside Warns of Ketamine Risks at American Colleges and Universities

NEW YORK--(BUSINESS WIRE)--As recent headlines ignite conversations about ketamine use across campuses, Mountainside Treatment Center is urging colleges and universities to ensure students have clear information about the dangers of ketamine and to make support available to the campus community. Ketamine was first synthesized in 1962 and approved by the U.S. FDA in 1970. It is primarily used as an anesthetic in medical settings but has gained attention for its off-label use in treating conditio...
Back to Newsroom